Denver, Colorado Clinical Trials

A listing of Denver, Colorado clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 63 clinical trials
Evaluation of Thiw he Gluw 'Akapi Substance Use Prevention Program

Researchers at the Centers for American Indian and Alaska Native Health in the Colorado School of Public Health at the University of Colorado completed an intensive community-engaged process to rigorously adapt the Strengthening Families Program for Parents and Youth 10-14 for the cultural context of a Northern Plains reservation community, …

suicide
drug abuse
substance use prevention
substance use
University of Colorado Anschutz Medical Campus
 (8.2 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • 1 location
A Study of Tirzepatide (LY3298176) Compared With Dulaglutide on Major Cardiovascular Events in Participants With Type 2 Diabetes

The purpose of the trial is to assess the efficacy and safety of tirzepatide to dulaglutide in participants with type 2 diabetes and increased cardiovascular risk.

tirzepatide
cardiovascular disease
body mass index
dulaglutide
Veteran's Affairs Medical Center
 (8.2 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +650 other locations
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer ALCHEMIST Chemo-IO Study

This phase III ALCHEMIST trial compares the addition of pembrolizumab to usual chemotherapy versus usual chemotherapy for the treatment of stage IB, II, or IIIA non-small cell lung cancer that has been removed by surgery. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the …

sarcoma
lung non-small cell squamous carcinoma
cisplatin/gemcitabine
small cell lung cancer
pemetrexed
Colorado Blood Cancer Institute
 (1.1 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +358 other locations
A Phase 3 Study to Evaluate Efficacy and Safety of AL001 in Frontotemporal Dementia (INFRONT-3)

A phase 3 double blind, placebo controlled study evaluating the efficacy and safety of AL001 in participants at risk for or with frontotemporal dementia due to heterozygous mutations in the progranulin gene.

dementia
pick's disease
progranulin
aphasia
University of Colorado
 (8.2 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +46 other locations
A Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With Migraine

The reason for this study is to see if lasmiditan is safe and effective in children aged 6 to 17 with migraine. The study will last up to 20 weeks and may include up to 4 visits.

migraine
treatment regimen
preventive medication
ly573144
lasmiditan
Children's Hospital Colorado
 (8.2 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +162 other locations
Tofacitinib for Immune Skin Conditions in Down Syndrome

People with Down syndrome (DS) display widespread immune dysregulation, including several immune skin conditions. This study hypothesizes that pharmacological inhibition of the increased interferon (IFN) signaling seen in DS is safe and could improve associated skin conditions. The study evaluates the safety and efficacy treatment with Tofacitinib, an FDA-approved drug …

dermatosis
hair thinning
antimicrobials
interferon
skin disorder
Linda Crnic Institute for Down Syndrome
 (8.2 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • 1 location
P-PSMA-101 CAR-T Cells in the Treatment of Subjects With Metastatic Castration-Resistant Prostate Cancer (mCRPC)

An open-label, multi-center, single and cyclic ascending dose study of P-PSMA-101 autologous CAR-T cells in patients with mCRPC.

rimiducid
metastatic hormone refractory prostate cancer
metastatic cancer
measurable disease
prostate cancer
Sarah Cannon Research Institute at HealthONE
 (1.1 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +2 other locations
Tipifarnib for the Treatment of Advanced Solid Tumors Lymphoma or Histiocytic Disorders With HRAS Gene Alterations a Pediatric MATCH Treatment Trial

This phase II pediatric MATCH trial studies how well tipifarnib works in treating patients with solid tumors that have spread to other places in the body (advanced), lymphoma, or histiocytic disorders that have HRAS genetic alterations. Tipifarnib may block the growth of cancer cells that have specific genetic changes in …

anticonvulsants
melanoma
HRAS
recurrent hepatoblastoma
solid tumors
Children's Hospital Colorado
 (8.2 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +82 other locations
A Phase 3 Safety and Efficacy Study of Intravitreal Administration of Zimura (Complement C5 Inhibitor)

The objectives of this study are to evaluate the safety and efficacy of Zimura intravitreal administration in patients with geographic atrophy secondary to age-related macular degeneration (AMD)

complement c5
geographic atrophy
atrophy
maculopathy
macular degeneration
University of Colorado
 (8.2 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +22 other locations
Evaluation of Updated Continuous Glucose Monitoring (CGM) Form Factor in Adults Adolescents and Pediatrics

The purpose of this study is to demonstrate the performance of the Disposable Sensor (DS5) in subjects age 2 - 80 years, for the span of 170 hours (7 days).

type 2 diabetes mellitus
diabetes
insulin sensitivity
continuous glucose monitoring
insulin
Barbara Davis Center for Childhood Diabetes
 (8.2 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +12 other locations